Abstract: The present disclosure provides a tea plant CsFAAH6 gene and use thereof. The tea plant CsFAAH6 gene has a nucleotide sequence shown in SEQ ID NO: 1 in sequence listing. A protein coded by the tea plant CsFAAH6 gene has an amino acid sequence shown in SEQ ID NO: 2 in the sequence listing. The CsFAAH6 is highly expressed in mature leaves of tea plants; there is significant negative correlation between theanine content in shoots (one bud and two leaves) of different tea cultivars in different months and expression level of the CsFAAH6; instantaneous silencing of CsFAAH6 expression can significantly increase the theanine content, indicating that CsFAAH6 has a physiological function of theanine degradation and a molecular mechanism thereof.

Abstract: The present invention provides a capsule endoscope, including: a power supply component; a power utilization component, comprising an image acquisition component; at least one power storage component, which is connected in parallel with the power supply component to form a power pack, the power storage component and the power supply component jointly providing power for the image acquisition component. According to the capsule endoscope, a capacitor, the power supply component and the like work in conjunction to supply power to a power utilization component, so that a peak power supply quantity can be increased, and the power utilization requirement can be met even if a high-power-consumption power utilization component operates. A multi-capacitor parallel connection mode is used in more than one power pack, so that the overlarge size of a single capacitor and possible safety risks can be avoided, and power distribution can be achieved.

Abstract: An end effector includes a substantially U-shaped stationary jaw located distally and a movable jaw movable relative to the stationary jaw to clamp tissue therebetween. The stationary jaw includes an anvil. The movable jaw is configured to receive a staple cartridge. A surface of the anvil opposite to the movable jaw defines a tissue engagement surface that defines a longitudinal axis and includes first and second staple forming pocket pairs located at two sides of the longitudinal axis. The first staple forming pocket pair and the second staple forming pocket pair each are configured as a centrosymmetric structure formed by two staple forming pockets arranged along the longitudinal axis. The staple forming pocket has an asymmetric shape. Corresponding staple forming pockets in the first and second staple forming pocket pairs are opposite to each other in shape orientation along a transverse direction perpendicular to the longitudinal axis.

Abstract: An acceleration resource scheduling method includes: receiving an acceleration instruction sent by the virtual machine, where the acceleration instruction includes to-be-accelerated data; determining a virtual accelerator allocated to the virtual machine; determining, based on the virtual accelerator, a network accelerator that is to process the acceleration instruction, and sending the acceleration instruction to the network accelerator, so that the network accelerator sends the acceleration instruction to a physical accelerator that is to process the acceleration instruction; receiving a computing result that is returned after the physical accelerator performs acceleration computing on the to-be-accelerated data by using the physical acceleration resource; and sending the computing result to the virtual machine.

Abstract: Described herein is a kinase inhibitor compound represented by formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug of the compound. Further described herein is a pharmaceutical composition containing the kinase inhibitor compound, as well as methods of using the compound to inhibit cKIT (especially mutant cKIT/T670I), FLT3 (comprising mutant FLT3-ITD), PDGFR?, PDGFR?, and/or VEGFR2 kinase activity in cells or a subject, and methods for preventing or treating disorders related to cKIT (especially mutant cKIT/T670I), FLT3 (comprising mutant FLT3-ITD), PDGFR?, PDGFR?, and/or VEGFR2 activity in a subject.

Abstract: An electronic water pump, including: a pump head, a pump housing, an isolation sleeve, an impeller assembly, a first gasket, and a rotation stopping structure, wherein a mounting portion is disposed on the pump head; the pump head is used for sealing the pump housing; the isolation sleeve is disposed between the pump head and the pump housing; the impeller assembly is disposed between the pump head and the isolation sleeve; and the first gasket is disposed at an end of the mounting portion that is close to the impeller assembly, and the first gasket is used for isolating the mounting portion from the impeller assembly.

Abstract: An electric water pump including a rotor assembly, wherein the rotor assembly includes an iron core body having a central through-hole, a plurality of magnetic plates disposed inside the iron core body, a first plastic coating layer for enclosing the iron core body, and a second plastic coating layer. At least one protruding rib is provided on a top surface and/or a bottom surface of the first plastic coating layer, a recess matching the protruding rib is provided on the second plastic coating layer, and the first plastic coating layer can drive the second plastic coating layer to rotate relative to an axis of the central through-hole of the iron core body.

Abstract: In a transmission rate determining method, a proximity coupling device (PCD) sends an activation frame to a proximity integrated circuit card (PICC). The activation frame indicates at least a first transmission rate used to transmit a first information frame and a second transmission rate used to transmit a target frame. The first information frame is used to transmit application information. The target frame includes at least one of a second information frame or a third information frame, the second information frame is used to transmit receive ready information, and the third information frame is used to transmit control information. The PCD receives an acknowledgment frame from the PICC. The acknowledgment frame indicates that the PICC has received the activation frame. Then, the PCD transmits the first information frame with the PICC at the first transmission rate, and transmits the target frame with the PICC at the second transmission rate.

Abstract: A driver and a control valve are provided. The control valve includes a valve body, a first valve core and a second valve core. The valve body provided with a valve cavity. A side wall of the valve body is provided with a plurality of communicating holes, and the communicating hole penetrates through the side wall of the valve body and is in communicate with the valve cavity. The first valve core is rotatably disposed at one end of the valve cavity, the first valve core is provided with a plurality of first passages and a plurality of second passages on a circumferential side of the first valve core. The second valve core is rotatably disposed at the other end of the valve cavity, and the second valve core is coaxially disposed with the first valve core, and the second valve core is coaxially disposed with the first valve core.

Abstract: An audio processing method includes obtaining a current to-be-recognized target audio block of a to-be-recognized audio, recognizing text information corresponding to the target audio block to obtain an audio block recognition result, based on the audio block recognition result, determining a first sub-block recognition result corresponding to a current sub-block formed by a starting audio block to the target audio block of the to-be-recognized audio, performing a combination process on identical text sequences of the first sub-block recognition result corresponding to different recognition paths, determining a second sub-block recognition result of the current sub-block based on a result of the combination process, and determining a text recognition result of the to-be-recognized audio based on the second sub-block recognition result.

Abstract: The invention provides a compound containing a 1,3-benzodioxol structure and a preparation method and use thereof. The invention discloses a 1,3-benzodioxol derivative as shown in general formula (1). Results of pharmacological experiments indicate that compound (I) of the invention can exert excellent inhibition on both BTK and JAK3 kinases, and can be used to prepare medicines for treating rheumatoid arthritis caused by over-activation of BTK and/or JAK3 pathways. The invention further discloses a preparation method for the 1,3-benzodioxol derivative.

Abstract: A data read/write method includes: establishing a first connection to a client, determining a first tablespace corresponding to the first connection, and determining a first node corresponding to the first connection or the first tablespace in a plurality of nodes, where the first connection receives a read/write request from the client; loading data in the first tablespace to a memory in the first node, and processing a read/write request on the first connection using a first working thread, where the first working thread is generated by a processor in the first node.

Abstract: The present disclosure provides a tea plant CsVAAT3 gene and use thereof. The tea plant CsVAAT3 gene has a nucleotide sequence shown in SEQ ID NO: 1 in sequence listing. A protein coded by the tea plant CsVAAT3 gene has an amino acid sequence shown in SEQ ID NO: 2 in the sequence listing. An expression pattern of CsVAAT3 in tea plant is significantly positively correlated with the nitrogen level in tea roots. The CsVAAT3 is highly expressed in tea roots. A pDR196-CsVAAT3 plasmid constructed from this gene is transformed into a vacuolar amino acid uptake-deficient yeast strain ypq2, which can restore the growth ability of the yeast mutant on a high-concentration theanine medium. Cloning of the gene is beneficial to analysis of a molecular mechanism of theanine storage in tea roots, providing an important target gene resource and a theoretical basis for cultivation of new tea cultivars with high theanine content.

Abstract: A bare-metal server of a cloud storage management system comprises a system-on-chip (Soc) and a processor. The SoC receives a volume attaching request sent by a public cloud management component of the management system. The volume attaching request includes an identifier of a system volume storing a file for starting an operating system of a bare-metal server of the management system. The SoC stores the identifier of the system volume based on the volume attaching request. When the bare-metal server of the management system is started, the bare-metal server uses the identifier of the system volume to the system volume, and starts an operating system by means of the SoC accessing the system volume.

Abstract: A data forwarding chip and a server are disclosed. The server includes a data forwarding chip, a network interface card, and a processor. The data forwarding chip is separately connected to the network interface card and the processor through a bus. After receiving a data forwarding request sent by the processor or the network interface card, the data forwarding chip forwards, based on a destination address of the data forwarding request through an endpoint port that is on the forwarding chip and that is directly connected to a memory space corresponding to the destination address of the data forwarding request, to-be-forwarded data specified in the data forwarding request, such that when the server sends or receives data, cross-chip transmission of data between processors occurs, thereby reducing a data transmission delay.

Abstract: The present disclosure provides a tea plant CsFAAH6 gene and use thereof. The tea plant CsFAAH6 gene has a nucleotide sequence shown in SEQ ID NO: 1 in sequence listing. A protein coded by the tea plant CsFAAH6 gene has an amino acid sequence shown in SEQ ID NO: 2 in the sequence listing. The CsFAAH6 is highly expressed in mature leaves of tea plants; there is significant negative correlation between theanine content in shoots (one bud and two leaves) of different tea cultivars in different months and expression level of the CsFAAH6; instantaneous silencing of CsFAAH6 expression can significantly increase the theanine content, indicating that CsFAAH6 has a physiological function of theanine degradation and a molecular mechanism thereof.